UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Position in Agilent Technologies, Inc. (NYSE:A)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Agilent Technologies, Inc. (NYSE:A) by 9.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,231,981 shares of the medical research company’s stock after purchasing an additional 283,445 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 1.13% of Agilent Technologies worth $434,184,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. CKW Financial Group boosted its stake in Agilent Technologies by 114.9% during the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 100 shares during the last quarter. Global X Japan Co. Ltd. boosted its stake in Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 116 shares during the last quarter. Redwood Park Advisors LLC bought a new position in Agilent Technologies during the 4th quarter valued at $27,000. Lee Danner & Bass Inc. bought a new position in Agilent Technologies during the 4th quarter valued at $29,000. Finally, Hanson & Doremus Investment Management lifted its position in shares of Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after buying an additional 105 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on A. Jefferies Financial Group reduced their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a research report on Monday, April 21st. Robert W. Baird reduced their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research report on Thursday, February 27th. TD Cowen raised their price target on shares of Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. Barclays reduced their price target on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. Finally, Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a research report on Thursday, April 17th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and an average target price of $143.00.

Agilent Technologies Stock Up 0.0%

A stock opened at $113.48 on Wednesday. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $154.65. The firm’s 50-day simple moving average is $110.23 and its 200 day simple moving average is $127.89. The stock has a market cap of $32.35 billion, a PE ratio of 26.09, a price-to-earnings-growth ratio of 3.20 and a beta of 1.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.54 EPS for the current year.

Insider Buying and Selling at Agilent Technologies

In other news, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now owns 35,737 shares of the company’s stock, valued at $4,161,931.02. The trade was a 4.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05% decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.